Order intake and organic growth improved in Q2 2026, with strong performance in Kanthal and resilience in Tube. Market uncertainty and geopolitical risks persist, but the order book remains robust and capex guidance is unchanged for FY 2026.Original document: Alleima AB [ALLEI] Slides Release — Jul…
Order intake and organic growth improved in Q2 2026, with strong performance in Kanthal and resilience in Tube. Market uncertainty and geopolitical risks persist, but the order book remains robust and capex guidance is unchanged for FY 2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.